Latest immunotherapy News

Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not…
Immunotherapy may temporarily restore fertility in patients of premature menopause
Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul
Recipients Of CIMED Project Grants 2027-2029 At MedH
Three young researchers backed to change the future for Aussie kids with deadly cancers
Backing Research Into New Treatments For Children’s Cancer
World’s largest genetic study of ‘moliness’ helps unravel mysteries of melanoma
Some immune cells can limit the effect of cancer immunotherapy
Experimental treatment kills prostate tumor cells while reawakening antitumor immunity
Björn Gysell and Family donate 80 million to research on future prostate cancer therapy
New acute care and cancer treatment services for Dargaville
EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden
AMA President’s update: King’s Birthday Honours, bulk billing assignment changes, RSV, residential aged care, and more
Kanvas Biosciences raises $48 million to advance microbiome cancer therapies
Hay fever, antihistamines and the evidence on dementia risk
Radiotherapy Provides Benefit In Advanced Melanoma
Yes, you really can be allergic to exercise – and the symptoms can be serious
‘Incredible’ Hodgkin Lymphoma Clinical Trial Study
Cheaper Medicines For People Fighting Leukaemia And Migraines
From Italy to KI – Paolo wants to contribute to future cancer treatments
Noosa woman to walk 25km in her stepdad’s memory following his rare prostate cancer diagnosis
US FDA decision date extended for SERENA-6 filing of camizestrant to enable review of additional data
Simple blood test could lead to personalised lung cancer treatment
Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who…
Focus on the heart and immune system: CRC continues research
‘Unexpected and genuinely exciting’: scientists capture immune cells attacking live melanoma
Monash secures $5.4 million in ARC Linkage funding for research projects
International Clinical Trials Day highlights importance of investing in medical research
Advances In Diagnosis And Treatment
Vitamin B12: the essential nutrient with a complicated cancer link
“My Daughter Got Me Through”: Christina’s Story
T Cells Secrete DNA To Help Immune System Fight Cancer
EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial
Monash University and partners boost south-east Melbourne’s launchpad for cancer research and clinical trials
Choosing cancer treatment options: what matters most when making decisions
How To Remove Metabolic Tattoo
Drug developer acquires potential cancer treatment discovered by QIMR Berghofer researcher
Backing Tasmania’s Lifesaving Jack Jumper Treatment And Research
Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
Recipients Of OnkPat’s 2026 Blue Sky Grant Announced
Shields and bodyguards: scientists uncover the hidden defences of a deadly childhood cancer
WA researchers develop RNA treatment to enhance cancer immunotherapy
New treatment reduces recurrence and improves survival in bladder cancer
Expanded Immunotherapy PBS Listing To Treat More Cancers
Ludwig Lausanne’s Ping-Chih Ho Elected AAAS Fellow
The Swedish Cancer Society funds seven research positions at OnkPat
Masked T-cell engagers: cancer immunotherapies for the future?
Immune Cells Are Programmed Within Body To Fight Cancer